Cardiac-Vascular Nursing (CVRN) Practice Exam

When a patient states they no longer want to participate in an experimental cardiac drug study, the nurse should advise that?

1. He or she has the right to refuse the medication and withdraw from the study

2. Participation in the study is critical to improving the quality of patient outcomes

3. The medication dose has been scheduled for administration

4. The primary investigator will speak with the patient about his or her decision

The correct answer is: He or she has the right to refuse the medication and withdraw from the study

The appropriate response in this scenario is based on the ethical principles governing clinical research, particularly informed consent and the right of autonomy. When a patient expresses a wish to withdraw from an experimental cardiac drug study, it is essential to affirm that they have the inherent right to make decisions about their own healthcare, including the right to refuse participation in a study. This principle is foundational in clinical research, ensuring that individuals can freely choose whether to continue or withdraw from a study without any coercion or penalty. Informed consent is a continuous process, which means the patient can change their mind at any time. It is crucial for healthcare professionals, including nurses, to respect this decision, ensuring that the patient understands they are in control of their participation. By advising the patient of this right, the nurse not only supports the patient's autonomy but also reinforces the ethical standards of clinical trials, which prioritize patient rights and welfare above all else.